HIV Treatment Innovation Module 2: Management of Common Comorbidities for People Living with HIV
This module provides considerations for managing and preventing common comorbidities, co-infections and opportunistic infections among PWH.
EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants should be able to:
- Identify common comorbidities and co-infections (CIs) among people with HIV and their impact on treatment decisions
- Summarize recent updates to HIV treatment guidelines related to co-infections and opportunistic infections (OIs)
- Identify strategies to manage common comorbidities and co-infections, including notable medication contraindications
- Explain the importance of prevention and wellness discussions with PWH, that includes vaccinations, to reduce impact of CIs and OIs
FACULTY
David Alain Wohl, MD
Professor of Medicine in the Division of Infectious Diseases, University of North Carolina School of Medicine
Co-Principal Investigator, Global UNC Infectious Diseases Clinical Trial Unit
Site Leader, HIV Prevention and Treatment Clinical Trials Unit, Chapel Hill, NC
Other Related Trainings
HIV Treatment Innovation Module 1: Innovations in Antiretroviral Therapies to Optimize HIV Treatment
This module provides an update on recommended and investigational ARV therapies for optimal HIV care and treatment in HIV care, primary care, and general medicine.
HIV Treatment Innovation Module 3: Considerations in the Management of HIV in Older Adults
This module provides considerations for managing HIV care among older adults and long-term HIV survivors.
